GE HealthCare Technologies company profile
Company profile
GE HealthCare Technologies has 54,000 employees and is headquartered in Chicago, United States.
Sales outside the United States and China accounted for 45.7% of revenue in the fiscal year ended December 2025, while the United States accounted for 44.5% and China for 9.8%. The company develops, manufactures and sells equipment and digital software used to diagnose, treat and monitor patients. Its Imaging unit covers molecular imaging, CT, MR and X-ray systems, while its ultrasound and surgical visualization offerings serve areas such as cardiology and women's health. Other units supply patient monitoring, anesthesia and maternal infant care products, and a pharmaceutical diagnostics business provides contrast media and radiopharmaceuticals to radiology and nuclear medicine providers.
In the fiscal year ended December 2025, revenue reached 20.6 billion US dollars, up 4.8% from the previous year, and net income was 2.1 billion US dollars. The company was founded in 1892, is headquartered in Chicago, Illinois, and employs 54,000 people.
Company facts
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Headquarters
- 500 West Monroe Street, 60661, Chicago
- Employees
- 54,000
- Chief executive
- Peter Arduini
- Founded
- 1892
- Fiscal year
- January - December
- Listing
- GEHC · NASDAQ
- Indices
- Nasdaq 100S&P 500
- Currency
- USD
- ISIN
- US36266G1076
- Website
- gehealthcare.com
GE HealthCare Technologies and its competitors
The most similar companies by business and size
| Company | Country | Market cap | Employees | Operating margin | P/E (trailing 12 months) |
|---|---|---|---|---|---|
| GE HealthCare TechnologiesGEHC | United States | $37B | 54,000 | 13.8% | 17.3 |
| DexComDXCM | United States | $30.44B | 11,000 | 24.0% | 32.1 |
| SterisSTE | United States | $25B | 17,937 | 19.2% | 30.5 |
| Edwards LifesciencesEW | United States | $61.59B | 16,000 | 28.8% | 61.6 |
| Boston ScientificBSX | United States | $63.33B | 59,000 | 19.6% | 18.4 |
| Zimmer Biomet HoldingsZBH | United States | $19.19B | 17,000 | 16.7% | 25.6 |
Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.
